Natural Capsules Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 377 shares,. Its Average Traded Price (ATP) is ₹142.23, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹142.37.
Natural Capsules has an upper circuit limit of ₹151.75 and a lower circuit limit of ₹137.31. The total value traded stands at ₹53620.71, and the delivery percentage for the day is 73.13%.
The stock is currently traded with a market lot size of 1. Natural Capsules also offers a dividend yield of 0%.
Natural Capsules Share Price Chart
Natural Capsules Share Key Metrics
Volume
377.00
Market Cap
150.47 CR
LTQ@LTP
1@142.37
ATP
142.23
Var Margin
25.47 %
Circuit Range
137.31-151.75
Delivery %
73.13 %
Value
53620.71
ASM/GSM
No
Market Lot
1
Natural Capsules Resistance and Support
Pivot 145.68
Resistance
First Resistance
146.83
Second Resistance
149.12
Third Resistance
150.27
Support
First Support
143.39
Second Support
142.24
Third Support
139.95
Natural Capsules Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Natural Capsules Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-13 | Quarterly Results |
| 2026-08-12 | Quarterly Results & Pref. issue |
| 2026-05-27 | Audited Results |
| 2026-02-13 | Quarterly Results |
| 2025-08-04 | Quarterly Results |
| 2025-05-29 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
| 2024-07-26 | Preferential issue of shares |
Natural Capsules News
Natural Capsules Ltd - 524654 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Promoter Sunil Laxminarayana Mundra acquired 1.12 lakh equity shares and 4.50 lakh fully convertible equity warrants through a preferential allotment. Following this transaction, the total diluted promoter and promoter group shareholding increased to 53.43%.
Nov 16 2026 10:10:19
Natural Capsules Ltd - 524654 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Natural Capsules announced its Q2 FY27 results with revenue of Rs.51.15 crores, up 12% YoY, and an EBITDA of Rs.3.01 crores, a 440% YoY increase. The company added Mankind Pharma as a customer and completed an audit by Zydus Lifesciences.
Nov 15 2026 21:23:39
Natural Capsules Ltd - 524654 - Announcement under Regulation 30 (LODR)-Allotment
Natural Capsules board approved the preferential allotment of 1,12,500 equity shares and 4,50,000 fully convertible warrants to promoter Sunil L Mundra. The allotment was made at an issue price of Rs.178 per share and warrant.
Nov 13 2026 19:30:39
Natural Capsules Ltd - 524654 - Update on board meeting
Natural Capsules board will meet on 13 Nov 2026 to consider Q2 FY27 financial results. The agenda includes a proposal for the preferential allotment of 1,12,500 equity shares and 4,50,000 warrants to promoter Sunil Laxminarayan Mundra.
Nov 10 2026 22:31:54
Natural Capsules Ltd - 524654 - Board Meeting Intimation for Considering And Approve The Unaudited Consolidated & Standalone Financial Results Of The Company For The Quarter & Half Yearly Ended September 30Th, 2026.
Natural Capsules board to meet on 13 November 2026 for financial results. The meeting will evaluate the company's half-yearly performance.
Nov 06 2026 15:49:49
Natural Capsules Management
| Name | Position |
|---|---|
| Tekkar Yashwanth Prabhu | Chairman |
| Laxminarayan Moondra | Whole Time Director |
Natural Capsules Similar Stocks
Natural Capsules FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in NATCAPSUQ
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC